1 hour ago
Moderna (MRNA) Stock Drops 4.6% Despite Groundbreaking Cancer Vaccine Breakthrough
Moderna (MRNA) stock fell 4.6% Friday despite breakthrough cancer vaccine results. Analysts project $3B sales by 2035. Price targets range $74-$135.
The post Moderna (MRNA) Stock Drops 4.6% Despite Groundbreaking Cancer Vaccine Breakthrough appeared first on Blockonomi.
Source: Blockonomi →Related News
- 12 minutes ago
Amazon (AMZN) Stock: E-Commerce Giant Secures 200MW Wind Energy in Swedish Data...
- 17 minutes ago
FreeCast, Inc. (CAST) Stock: Drops Slightly as Beyond Media Targets Telecom and...
- 37 minutes ago
Stock Futures Trade Flat as Investors Await Fed Chair Warsh’s Jackson Hole Addre...
- 41 minutes ago
Moderna, Inc. (MRNA) Stock: Slide as Company Upsizes Debt Offering to $2.6 Billi...
- 44 minutes ago
SentinelOne (S) Stock Surges 10% Following Strong Q2 Earnings Beat